Update in Women's Health
Authors: Molly Carnes, Jane E. Mahoney
Journal: Annals of Internal Medicine (2004)

Updates from the Annual Session6 April 2004Update in Women's HealthMolly Carnes, MD, MS and Jane E. Mahoney, MDMolly Carnes, MD, MSFrom the University of Wisconsin, Madison, Wisconsin.Search for more papers by this author and Jane E. Mahoney, MDFrom the University of Wisconsin, Madison, Wisconsin.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-140-7-200404060-00014 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Women's health for the internist generally encompasses nonobstetric reproductive health, sex and gender differences in diseases that occur in both men and women, and conditions that occur predominantly or uniquely in women. This year's Update in Women's Health involves 11 manuscripts published in 2002 that potentially change standards of care. The manuscripts fall into the following categories: genitourinary conditions, hormone therapy, cardiovascular disease, and breast cancer.Genitourinary ConditionsHuman Papillomavirus Type 16 Vaccine Reduced the Incidence of Both HPV-16 Infection and HPV-16–Related Cervical Intraepithelial Neoplasia Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus ...References1. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338:423-8. [PMID: 9459645] CrossrefMedlineGoogle Scholar2. Diokno AC, Brock BM, Brown MB, Herzog AR. Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol. 1986;136:1022-5. [PMID: 3490584] CrossrefMedlineGoogle Scholar3. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al . Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998;280:605-13. [PMID: 9718051] CrossrefMedlineGoogle Scholar4. Hays J, Ockene JK, Brunner RL, Kotchen JM, Manson JE, Patterson RE, et al . Effects of estrogen plus progestin on health-related quality of life. N Engl J Med. 2003;348:1839-54. [PMID: 12642637] CrossrefMedlineGoogle Scholar5. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA. 1995;273:199-208. [PMID: 7807658] CrossrefMedlineGoogle Scholar6. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med. 1997;336:525-33. [PMID: 9036306] CrossrefMedlineGoogle Scholar7. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldmanmd AM, Francis GS, et al . ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America. Circulation. 2001;104:2996-3007. [PMID: 11739319] MedlineGoogle Scholar8. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001;22:1527-60. [PMID: 11492984] CrossrefMedlineGoogle Scholar9. Heart Failure Society of America (HFSA) practice guidelines. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction—pharmacological approaches. J Card Fail. 1999;5:357-82. [PMID: 10634677] CrossrefMedlineGoogle Scholar10. Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003;289:871-8. [PMID: 12588271] CrossrefMedlineGoogle Scholar11. Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:347-60. [PMID: 12204020] LinkGoogle Scholar12. Screening for breast cancer: recommendations and rationale. Ann Intern Med. 2002;137:344-6. [PMID: 12204019] LinkGoogle Scholar Author, Article, and Disclosure InformationAuthors: Molly Carnes, MD, MS; Jane E. Mahoney, MDAffiliations: From the University of Wisconsin, Madison, Wisconsin.Contributing Editor: Jennifer Fisher Wilson.Disclosures: None disclosed.Corresponding Author: Molly Carnes, MD, MS, Department of Medicine, General Clinical Research Center, University of Wisconsin Medical School, 1300 University Avenue, Madison, WI 53706; e-mail, mlcarnes@facstaff.wisc.edu.Current Author Addresses: Drs. Carnes and Mahoney: Department of Medicine, General Clinical Research Center, University of Wisconsin Medical School, 1300 University Avenue, Madison, WI 53706. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byFemale Genitalia 6 April 2004Volume 140, Issue 7Page: 538-544KeywordsBreast cancerEstradiolEstrogensHeart failureHormonal therapyHormonesMammographyMortalityOophorectomyVaccines ePublished: 6 April 2004 Issue Published: 6 April 2004 Copyright & PermissionsCopyright © 2004 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...